Aspirin & Investor
Investor
Have you ever thought about how predictive analytics could shave weeks off a clinical trial while keeping patient safety intact?
Aspirin
Predictive analytics is like having a crystal ball that only shows data, not fortune-telling. If we model outcomes early, we can trim a trial by weeks and still guard safety—think of it as tightening the safety net before it even has to catch a fall. It’s efficient, but we have to keep the models transparent and the patients as the top priority.
Investor
Sounds solid, but remember the model has to pass regulatory scrutiny—any blind spots could turn a cost saving into a liability. Keep the data clean and the assumptions documented; that's the only way the crystal ball stays in the lab and not in a courtroom.
Aspirin
Absolutely, regulatory compliance is the safety net for that crystal ball—without it, the whole model collapses. Clean data, clear documentation, and rigorous validation keep the risk at bay, so we stay in the lab, not on a courtroom stage. And if any blind spot pops up, we patch it before it turns into a liability.